VA
Valmark Advisers’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $375K | Sell |
3,385
-1
| -0% | -$111 | 0.01% | 492 |
|
|
2025
Q1 | $379K | Sell |
3,386
-105
| -3% | -$11.8K | 0.01% | 471 |
|
|
2024
Q4 | $322K | Sell |
3,491
-64
| -2% | -$5.91K | 0.01% | 494 |
|
|
2024
Q3 | $298K | Sell |
3,555
-618
| -15% | -$51.8K | ﹤0.01% | 501 |
|
|
2024
Q2 | $286K | Buy |
4,173
+384
| +10% | +$26.3K | ﹤0.01% | 480 |
|
|
2024
Q1 | $278K | Sell |
3,789
-447
| -11% | -$32.7K | ﹤0.01% | 466 |
|
|
2023
Q4 | $343K | Sell |
4,236
-726
| -15% | -$58.8K | 0.01% | 401 |
|
|
2023
Q3 | $372K | Sell |
4,962
-79
| -2% | -$5.92K | 0.01% | 368 |
|
|
2023
Q2 | $389K | Buy |
5,041
+82
| +2% | +$6.32K | 0.01% | 365 |
|
|
2023
Q1 | $411K | Buy |
4,959
+98
| +2% | +$8.13K | 0.01% | 346 |
|
|
2022
Q4 | $417K | Buy |
4,861
+618
| +15% | +$53.1K | 0.01% | 330 |
|
|
2022
Q3 | $262K | Sell |
4,243
-25
| -0.6% | -$1.54K | 0.01% | 366 |
|
|
2022
Q2 | $264K | Sell |
4,268
-17
| -0.4% | -$1.05K | 0.01% | 365 |
|
|
2022
Q1 | $255K | Sell |
4,285
-316
| -7% | -$18.8K | ﹤0.01% | 388 |
|
|
2021
Q4 | $334K | Sell |
4,601
-694
| -13% | -$50.4K | 0.01% | 331 |
|
|
2021
Q3 | $370K | Sell |
5,295
-171
| -3% | -$11.9K | 0.01% | 297 |
|
|
2021
Q2 | $376K | Buy |
5,466
+9
| +0.2% | +$619 | 0.01% | 301 |
|
|
2021
Q1 | $353K | Buy |
5,457
+1,366
| +33% | +$88.4K | 0.01% | 300 |
|
|
2020
Q4 | $238K | Buy |
+4,091
| New | +$238K | ﹤0.01% | 317 |
|